Drug development. Former postdoc @mgh_id+@harvardmed. @uqalumni
Melbourne, Victoria
Joined June 2019
- Tweets86
- Following313
- Followers119
- Likes318
Jason Paul Lynch, PhD retweeted
"My team have been developing these miniature lungs." #MCRI's Dr @RhiannonWerder has spoken to @ABCaustralia about her recent Metcalf Prize from @AusStemCell and how she is using #stemcells to examine lung infections. | #MedicalResearch
Full interview 👉 mcri.edu.au/news/awards/metc…
Jason Paul Lynch, PhD retweeted
‘Mini-lungs could help fight flu & colds by tapping immunity’ @CosmosMagazine reports on 2024 #MetcalfPrizes winner @RhiannonWerder @MCRI_for_kids cosmosmagazine.com/health/bo…
Jason Paul Lynch, PhD retweeted
We are seeking an enthusiastic, motivated and curious PhD student to join us at @MCRI_for_kids to study how viral infections lead to pulmonary fibrosis using stem cell models 🫁. More details here: findaphd.com/phds/project/ex…
Jason Paul Lynch, PhD retweeted
AdAlta's (ASX:1AD) CEO and MD Tim Oldham joined SYNthesis BioVentures's MD Professor Andrew Wilks on last Thursday's webinar to discuss the exciting partnership between SYNthesis and Adalta | investorhub.adalta.com.au/ac…
#1AD #Webinar
Jason Paul Lynch, PhD retweeted
AdAlta's (ASX:1AD) Chief Executive Officer and Managing Director Tim Oldham presented at @thestocknet's Gems Conference on Friday, 22 March 2024 | investorhub.adalta.com.au/ac…
#ASXGems #FDA #Phase1 #ibody #Phase2
Excited to be attending @DDB_MPGPCR hosted by @MIPS_Australia . Interested in finding out more about @AdAlta1AD i-body technology and progress developing AD-214? Check out our poster (87) to find out more. I’ll also be giving a talk tomorrow Nov 16th at 12.30 pm.
Jason Paul Lynch, PhD retweeted
Don’t forget to read @AdAlta1AD's first article on fibrosis, as part of our new education series & as we enter Pulmonary Fibrosis Awareness Month (Sep). Read: bit.ly/3ORUMVu #fibrosis #IPF #biotech #ASX #AdAlta
Jason Paul Lynch, PhD retweeted
Fibrosis is a serious condition impacting millions globally. At @AdAlta1AD we’re working on new therapeutics to treat it. As part of Pulmonary Fibrosis Awareness Month, we look at fibrosis, its impacts & how we’re working to treat it. Read article: bit.ly/3ORUMVu $1AD
Jason Paul Lynch, PhD retweeted
Bill Van Nierop is a past sufferer of IPF lung disease. He is doing the Long Kayak for Lungs 2 to raise awareness & funds for research. @AdAlta1AD are proud to sponsor Bill as we strive to develop therapeutics for fibrosis. Please support Bill’s mission: bit.ly/3pXvXiD
Jason Paul Lynch, PhD retweeted
Common colds caused by #rhinovirus can exacerbate #asthma via IL33 and NETosis from #neutrophils:
mucosalimmunology.org/articl…
Jason Paul Lynch, PhD retweeted
E. coli delivers! @JasonPLynch @Cammie_Lesser describe PROT3EcT, suite of #Ecoli w/modified bacterial secretion system for secretion of therapeutic payloads. Pretreating w/TNF-α-neutralizing nanobody-secreting PROT3EcT prevents #colitis in IBD model cell.com/cell-host-microbe/f…
Jason Paul Lynch, PhD retweeted
Congrats @JasonPLynch @theGarrettLab @Cammie_Lesser et al on @cellhostmicrobe pub! Funded partly by @CrohnsColitisFn, this work shows engineered E-coli can block #IntestinalInflammation through delivery of anti-TNF nanobodies to the gut in #IBD mouse model bit.ly/3U6RyzL
Jason Paul Lynch, PhD retweeted
Congrats @JasonPLynch @theGarrettLab @Cammie_Lesser et al on @cellhostmicrobe pub! Funded partly by @CrohnsColitisFn, this work shows how engineered E-coli can block #IntestinalInflammation by delivering anti-TNF nanobodies to the gut in #IBD mouse model bit.ly/3U6RyzL
Jason Paul Lynch, PhD retweeted
Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut
cell.com/cell-host-microbe/p…
Jason Paul Lynch, PhD retweeted
Congrats to @jduncanlowey and all on a great story pnas.org/doi/epdf/10.1073/pn…
Jason Paul Lynch, PhD retweeted
We have an open position in the lab for a Research Instructor. Full benefits, a cool research project, and great lab mates are included. Job ad below. please email me with any questions: [email protected]
cu.taleo.net/careersection/2…
Jason Paul Lynch, PhD retweeted
Postdoctoral position available!!! Gram-negative bacterial infectious disease pathogenesis and innate immune responses. [email protected]
Jason Paul Lynch, PhD retweeted
One week left to apply! Come and join us at @MCRI_for_kids, using stem cell models of the lung to understand respiratory disease. DM if you have any questions
We’re hiring! 2-yr postdoc position at @MCRI_for_kids using cutting-edge stem cell models and CRISPR screens to identify new treatments for respiratory infections 🫁 Any questions please reach out! Retweets appreciated career10.successfactors.com/…
Jason Paul Lynch, PhD retweeted
We’re hiring! 2-yr postdoc position at @MCRI_for_kids using cutting-edge stem cell models and CRISPR screens to identify new treatments for respiratory infections 🫁 Any questions please reach out! Retweets appreciated career10.successfactors.com/…
Jason Paul Lynch, PhD retweeted
Wonderful to finally see this out!! Great work Grace et al, a perfect way to celebrate the end of a successful PhD 🥳🥳
#Microbiota modulation of intestinal epithelial homeostasis. @theGarrettLab show F. rodentium promotes epithelial proliferation & turnover by dampening retinoic acid production that supports survival of eosinophils, which suppress pro-proliferative IFNγ cell.com/cell-host-microbe/f…
